Diabetes guide history

Document Title

A guideline for management of diabetes in Palliative Care

Document Date

October 2022

Document Purpose and Intended Audience

Guideline to help avoid hypoglycaemia, limit symptomatic hyperglycaemia and avoid unnecessary blood sugar monitoring and complex insulin regimes. This guideline is intended for use by healthcare professionals working with palliative patients.


Dr Maddy Turley, Palliative Registrar, West Midlands

Consultation Process

Reviewed by SPAGG and ratified


This will be audited and reviewed every 3 years

Review Date

(must be within three years)

Dec 2025

Approval Signatures:

SPAGG chair

Dr Jon Tomas

SPAGG secretary

Dr Alice Gray

Date Approved by SPAGG: 13/11/19

Date submitted to Area Prescribing Committee: N/A

Version History

Version 1.1



Summary of change/ process

Reviewed by SPAGG and ratified

Disclaimer (SPAGG - Rewrite)

This Guide is intended for use by healthcare professionals and the expectation is that they will use clinical judgement, medical, and nursing knowledge in applying the general principles and recommendations contained within. They are not meant to replace the many available texts on the subject of palliative care.

Some of the management strategies describe the use of drugs outside their licensed indications. They are, however, established and accepted good practice. Please refer to the current BNF for further guidance.

While WMPCPS takes every care to compile accurate information , we cannot guarantee its correctness and completeness and it is subject to change. We do not accept responsibility for any loss, damage or expense resulting from the use of this information.